This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Quality of Life  • Colorectal Surgery  • Gastrointestinal/ Upper Foregut  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Robert A. Kozol,, MD

Arch Surg. 2007;142(7):611.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Kubota et al offer an alternative procedure for the relief of the vexing problem of malignant GOO in patients with tumors that are not resectable. While their procedure (SPGJ) may be a useful addition to available options, the suggestion that this is a fair comparison with endoscopic stenting is misleading. In the study by Kubota et al, Figure 3 reveals that 81% of patients in both groups were dead at 1-year follow-up. However, the median survival in the stent group was only 2.8 months (compared with 7.3 months in the SPGJ group). The patients in the stent group weighed a mean of 10 kg less than those in the SPGJ group. Finally, almost half of the stent group had advanced pancreatic or ovarian cancer. These facts strongly suggest that the patients in the stent group were more ill or had more advanced malignant neoplasms. This may . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Stomach-Partitioning Gastrojejunostomy for Gastroduodenal Outlet Obstruction
Keisuke Kubota, Junko Kuroda, Nobuto Origuchi, Michio Kaminishi, Hiromichi Isayama, Takao Kawabe, Masao Omata, and Ken-ichi Mafune
Arch Surg. 2007;142(7):607-611.
ABSTRACT | FULL TEXT